StockDriftsStockDriftsKwangdong Pharmaceutical (009290) has 0 disclosed insider purchases and 1 disclosed disposals on record, filed by 1 distinct insiders. Together those filings cover ₩352K ($245) in reported transaction value. The earliest filing StockDrifts holds for Kwangdong Pharmaceutical is dated 2020-07-23; the most recent is 2026-03-06. Across these filings the average return since disclosure is +9.30%, measured from each filing date to the latest available close.
| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2026-03-06 | BUY | 기타 | 구준모 Goo Jun-mo | Managing Director | 2.6K | ₩8,820 | +0.7% | ₩23M ($16K) |
| 2026-02-27 | BUY | 주식매수선택권 | 이채주 Chaeju Lee | Managing Director | 5.9K | ₩9,540 | -6.9% | ₩56M ($39K) |
| 2026-02-27 | BUY | 주식매수선택권 | 박상영 Sangyoung Park | CEO (President) | 7.3K | ₩9,540 | -6.9% | ₩70M ($49K) |
| 2026-02-27 | BUY | 주식매수선택권 | 이강주 Kangju Lee | Managing Director | 4.7K | ₩9,540 | -6.9% | ₩45M ($31K) |
| 2026-02-27 | BUY | 주식매수선택권 | 구준모 Goo Jun-mo | Managing Director | 5.3K | ₩9,540 | -6.9% | ₩50M ($35K) |
| 2026-02-27 | BUY | 주식매수선택권 | 박원호 Wonho Park | Managing Director | 6.6K | ₩9,540 | -6.9% | ₩63M ($44K) |
| 2026-02-27 | BUY | 주식매수선택권 | 설상현 Seol Sang-hyeon | Managing Director | 5.9K | ₩9,540 | -6.9% | ₩56M ($39K) |
| 2026-02-27 | BUY | 주식매수선택권 | 배기룡 Bae Ki-ryong | Managing Director | 5.9K | ₩9,540 | -6.9% | ₩56M ($39K) |
| 2020-07-23 | SELL | Market Sell | 이강주 Kangju Lee | Managing Director | -36 | ₩9,790 | +9.3% | ₩352K ($245) |
Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.